A recent study published in the New England Journal of Medicine assessed the risk of new-onset psychosis among adolescents and young adults with attention deficit hyperactivity disorder (ADHD) initiated on various stimulant medications.
Analyzing personality characteristics and risk behaviors of youth who use synthetic cannabinoids may prevent addiction and adverse effects associated with drug use.
Comorbid bipolar I disorder and conduct disorder may represent a distinct familial subtype, providing valuable information for future clinicians.
Maternal prenatal vitamin intake during the first month of pregnancy may reduce the risk for autism spectrum disorder recurrence in siblings of children with ASD.
Previous research indicated that estradiol and testosterone were linked to depression in adolescent girls, as opposed to testosterone alone.
Treatment with dasotraline (4 mg/day) significantly improves ADHD symptoms in children aged 6 to 12 years.
Infants who have multiple moderate-to-severe regulatory problems have increased odds of experiencing mental health problems during childhood.
Preventive strategies to reduce cannabis use among youth are needed, as adolescent cannabis consumption is associated with increased risk for depression and suicidal behavior later in life.
Social media use does not predict later depressive symptoms among adolescents or college undergraduates.
A psychoeducational social support intervention involving youth-nominated caring adults, was associated with reduced mortality in suicidal adolescents.
